Dow Jones
33.849,46 -497,57 (-1,45%) Nasdaq
11.049,50 -176,86 (-1,58%) Nikkei 225
27.989,71 -173,12 (-0,61%) EUR/USD
1,0338 -0,0006 (-0,06%) BTC-EUR
15.659,28 -280,72 (-1,76%) CMC Crypto 200
379,50 -0,79 (-0,21%)
Certara, Inc. (CERT)
Dopo ore:
| Chiusura precedente | 15,88 |
| Aperto | 15,81 |
| Denaro | 15,04 x 800 |
| Lettera | 15,79 x 900 |
| Min-Max giorno | 15,70 - 16,25 |
| Intervallo di 52 settimane | 10,60 - 29,99 |
| Volume | |
| Media Volume | 781.646 |
| Capitalizzazione | 2,518B |
| Beta (5 anni mensile) | N/D |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,09 |
| Prossima data utili | 27 feb 2023 - 03 mar 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 20,56 |
- GlobeNewswire
Certara Reports Third Quarter 2022 Financial Results
Biosimulation software and services fuel third quarter growthPRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the third quarter of fiscal year 2022 and reiterated its full year guidance. Third Quarter Highlights: Revenue was $84.7 million, compared to $73.9 million in the third quarter of 2021, representing growth of 15% over the third quarter of 2021 on a reported basis and 18% at constant
- GlobeNewswire
Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of sharesPRINCETON, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare companies, has committed to make a new $449M investment in Certara. Arsenal currently owns approximately 4% of com
- GlobeNewswire
Certara to Participate in Upcoming Investor Conferences
PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences: Jeffries London Healthcare ConferenceDate and Time: Tuesday, November 15 at 4:25PM GMT Stephens Annual Investment ConferenceDate and Time: Thursday, November 17 at 9:00AM CT Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.c
